4th ESPT summer school: precision medicine and personalised health.


Journal

Pharmacogenomics
ISSN: 1744-8042
Titre abrégé: Pharmacogenomics
Pays: England
ID NLM: 100897350

Informations de publication

Date de publication:
05 2019
Historique:
entrez: 25 5 2019
pubmed: 28 5 2019
medline: 14 4 2020
Statut: ppublish

Résumé

In September 2018, the European Society of Pharmacogenomics and Personalised Therapy (ESPT), with the support of the Swiss Personalized Health Network (SPHN), organized its 4th biennial summer school, entitled 'Precision Medicine and Personalised Health' (Campus Biotech, Geneva, Switzerland; www.esptsummerschool.eu/ ). The school's comprehensive and innovative educational program aimed to address the fundamentals of pharmacogenomics, the latest knowledge on established and new concepts in the field of precision medicine, as well as its advanced clinical applications in personalized health. The school consisted of 31 lectures, eight interactive workshops, visits to genome center and poster presentations, involving 40 speakers from distinguished international faculties. The meeting was a resounding success by generating informal environments between more than 80 participants from 26 different countries.

Identifiants

pubmed: 31124416
doi: 10.2217/pgs-2019-0008
doi:

Types de publication

Congress Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

471-474

Auteurs

Vid Mlakar (V)

CANSEARCH Research Laboratory, Department of Paediatrics, Faculty of Medicine, Geneva University, 1205 Geneva, Switzerland.

Janja Marc (J)

Department of Clinical Chemistry, Faculty of Pharmacy, University of Ljubljana, 1000 Ljubljana, Slovenia.

Vangelis G Manolopoulos (VG)

Laboratory of Pharmacology, Medical School, Democritus University of Thrace, 68100 Alexandroupolis, Greece.

Ingolf Cascorbi (I)

Institute of Experimental & Clinical Pharmacology, University Hospital Schleswig-Holstein Campus Kiel, 24105 Kiel, Germany.

Sanja Stanković (S)

Center for Medical Biochemistry, Clinical Center of Serbia, 11000 Beograd, Serbia.

Adrian Llerena (A)

CICAB Clinical Research Center, Extremadura University Hospital and Medical School, 06006 Badajoz, Spain.

Maurizio Simmaco (M)

Second Faculty of Medicine, St Andrea Hospital, Sapienza University of Rome, 00189 Rome, Italy.

Sophie Visvikis-Siest (S)

Université de Lorraine, Inserm, IGE-PCV, Nancy, France.

Ursula Amstutz (U)

University Institute of Clinical Chemistry, Inselspital, Bern University Hospital, University of Bern, INO-F, CH-3010 Bern, Switzerland.

Csilla Sipeky (C)

Institute of Biomedicine, University of Turku, 20520 Turku, Finland.

Urs A Meyer (UA)

Biozentrum, University of Basel, 4056 Basel, Switzerland.

Peter Meier-Abt (P)

Swiss Academy of Medical Sciences and Swiss Personalized Health Network, 3001 Berne, Switzerland.

Ron H van Schaik (RH)

Department of Clinical Chemistry, Erasmus MC University Medical Hospital, 3015CN Rotterdam, The Netherlands.

Marc Ansari (M)

CANSEARCH Research Laboratory, Department of Paediatrics, Faculty of Medicine, Geneva University, 1205 Geneva, Switzerland.
Oncology and Haematology Unit, Department of Paediatrics, Geneva University Hospital, 1211 Geneva, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH